Ашық рұқсат Ашық рұқсат  Рұқсат жабық Рұқсат берілді  Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

№ 2s (2012)

Articles

EPIDEMIOLOGIYa PERELOMOV PROKSIMAL'NOGO OTDELA BEDRENNOY KOSTI

Ershova O., Sinitsyna O., Belova K., Ganert O., Romanova M., Belov M.

Аннотация

Proximal femoral fractures are the most serious complications of osteoporosis. Their incidence varies in different countries. In the Russian Federation, epidemiology of this type of fractures was investigated in two multi-center studies. According to a recent study, in Russia high incidence of femoral fractures among men and modest among women was noted. Knowledge of the actual incidence of fractures should be the basis for the development of healthcare system for patients with proximal femoral fractures in our country.
Pharmateca. 2012;(2s):10-16
pages 10-16 views

KLINIChESKAYa VZAIMOSVYaZ' OSTEOPOROZA I ATEROSKLEROZA

Shishkova V.

Аннотация

The article considers the mechanisms of osteoporosis and atherosclerosis, which have linking these diseases. Evidence that osteoporosis, calcification of the aorta and heart valves, as well as atherosclerotic vascular disease are related pathological processes, are presented. It is emphasized that statins can favorably affect bone metabolism, and bisphosphonates, on the contrary, have a positive effect on the lipid profile. New approaches to prevention and treatment of osteoporosis based on use of combined drugs are discussed. Fosavans is one of these drugs, which combines powerful antiresorptive and anabolic aspects of osteoporosis therapy and contains the original alendronate at a dose of 70 mg and vitamin D3 at a dose of 2800 IU.
Pharmateca. 2012;(2s):17-21
pages 17-21 views

SOVREMENNOE LEChENIE OSTEOARTROZA

Alekseeva L.

Аннотация

Osteoarthrosis is the most common chronic disease of the joints. The pain and deterioration of joint function are main manifestations of osteoarthrosis, requiring their treatment. Currently, non-steroidal anti-inflammatory drugs, opioid analgesics, glucosamine and chondroitin sulfate, and application of unsaponifiable compounds of avocado and soybean are used for the treatment. The possibility of therapy with antiosteoporotic drugs, such as bisphosphonates, calcitonin, strontium ranelate, is discussed.
Pharmateca. 2012;(2s):22-27
pages 22-27 views

OSTEOARTROZ I METABOLIChESKIY SINDROM

Men'shikova I.

Аннотация

The article considers the pathogenetic relationship between two common diseases - osteoarthrosis (OA) and the metabolic syndrome (MS). The data on the role of inflammatory mediators, including adipokines, in the development of articular cartilage damage are presented. The presence of MS and its individual components is a risk factor for OA of various joints, especially in women and Asians, and the frequency of MS is higher in patients with OA. This correlation promotes search for common therapeutic approaches for these diseases.
Pharmateca. 2012;(2s):28-31
pages 28-31 views

OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA

Biryukova E.

Аннотация

Data on the main calcium-regulating hormones (parathyroid hormone, calcitonin) and their role in the regulation of bone remodeling are presented. These processes are also influenced by sex steroids, growth hormone, insulin, cortisol, thyroid hormones, and various local growth factors. In this regard, osteopenia and osteoporosis are closely linked with a number of endocrine diseases, some of which are common (diabetes mellitus, thyrotoxicosis), others - quite rare (endogenous hypercortisolism). The osteoporosis associated with diabetes, steroid osteoporosis, osteoporosis associated with thyroid function abnormalities are discussed in detail. It is emphasized that timely diagnosis and adequate treatment of endocrine diseases associated with decreased bone mineral density contribute to slowing or termination of bone loss, normalization of bone remodeling, can reduce the incidence of fractures and improve quality of life.
Pharmateca. 2012;(2s):32-39
pages 32-39 views

SOVREMENNYE PODKhODY K DIAGNOSTIKE I LEChENIYu OSTEOPOROZA

Lesnyak O.

Аннотация

Osteoporosis is a common disease characterized by bone mass loss and impaired microarchitectonics of bone tissue, leading to bone fragility and a predisposition to bone fracture. Current strategy of the management of osteoporotic patients includes early diagnosis with the definition of high risk of fractures, and early use of pathogenetic treatment. Modern methods of assessment of fracture risk (osteodensitometry and FRAX calculator) allow accurately predicting the risk and early beginning appropriate treatment. The modern arsenal of pathogenetic therapy of osteoporosis consist of drugs with two main action - antiresorptive agents (bisphosphonates, deno-sumab - suppressing excess osteoclastic bone resorption) and anabolic agents (parathyroid hormone drugs stimulating bone formation by osteoblasts), as well as dual-action drugs (strontium ranelate).
Pharmateca. 2012;(2s):40-44
pages 40-44 views

ISSLEDOVANIE GORMONAL'NOGO FONA U MUZhChIN S PERELOMAMI PROKSIMAL'NOGO OTDELA BEDRA

Ershova O., Sinitsyna O., Belova K., Svetalkina E., Ganert O., Romanova M., Kryukova T.

Аннотация

Osteoporotic fractures occur in 27 % of men aged 50 years and older, their risk further increases, but the problem of osteoporosis in men has been insufficiently studied. Purpose of study: evaluation of endocrine profiles in 128 men with proximal femoral fractures (PFF) aged 40-69 years in the cross-sectional study. Assessment of hormone levels was performed by electrochemiluminescence ECLIA., Elecsys 2010 (Roche). Statistical analysis was performed using Statistica 10.0 software. A significant decrease in testosterone levels and high levels of 17-estradiol and prolactin, as well as the high frequency of 25(OH)-vitamin D deficiency compared with controls, were observed in patients with PFF in study groups. Thus, PFF in men occur against the background of reducing the concentration of testosterone and the presence of 25 (OH)-vitamin D deficiency.
Pharmateca. 2012;(2s):45-49
pages 45-49 views

OSTEOARTROZ KOLENNYKh SUSTAVOV I MINERAL'NAYa PLOTNOST' KOSTI OSEVOGO SKELETA

Zaytseva E., Smirnov A., Demin N., Alekseeva L.

Аннотация

The article presents the results of study aimed to evaluation of relationship between bone mineral density (BMD) of the axial skeleton and age of osteoarthrosis (OA) onset. The study confirmed that individuals with high values of BMD in the lumbar spine develop OA at more young age. In addition, more severe radiographic changes in knee joints is specific characteristic in these patients.
Pharmateca. 2012;(2s):50-53
pages 50-53 views

OSTEOPOROZ: AKTUAL'NAYa PROBLEMA

Rozhinskaya L.

Аннотация

Osteoporosis is one of the most prevalent and socially significant diseases in the world. The article presents current data on the epidemiology, classification, pathogenesis and risk factors for osteoporosis. Particular attention is paid to the diagnosis - radiography, osteodensitometry, and laboratory methods. Drug treatment of osteoporosis using data from evidence based medicine is presented.
Pharmateca. 2012;(2s):54-63
pages 54-63 views

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>